Skip to Content
· Biorevitalisation
SKU 11211

Viscoderm 1.6

In stock
Volume
3 x 1,5 mL
Laboratory
IBSA
Origin
Italy
Indication
Biorevitalisation, biostimulation, age-related skin change
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Viscoderm 1.6 is an injectable biorevitalisation gel implant by Viscoderm, containing 24 mg of native hyaluronic acid per 1.5 ml syringe, with a molecular weight similar to endogenous hyaluronic acid. It is typically chosen by clinics, dermatologists and aesthetic practitioners for biostimulation of the face, neck, hands and decollete. The hyaluronic acid is obtained by biofermentation from natural raw materials and produced without chemical modification, and the product is developed for professional use by qualified practitioners.

Key Benefits of Viscoderm 1.6

  • Contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml
  • Supports skin biostimulation and biorevitalisation
  • Improves hydration and skin elasticity
  • Improves skin texture and the appearance of age-related skin changes
  • Formulated for the face, neck, hands and decollete
  • Native hyaluronic acid, obtained by biofermentation and not chemically modified
  • Supports good biocompatibility and tolerability
  • Suitable for different professional injection techniques
  • Sterile and apyrogenic syringe content
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Native hyaluronic acid, obtained by biofermentation and not chemically modified
Volume / Size 1.5 ml per syringe, 4.5 ml per pack
Packaging 3 syringes x 1.5 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.

Indications and Professional Use

Main indications

  • Moderate age-related skin changes
  • Genetically dry skin prone to fine lines
  • Skin affected by frequent or prolonged sunbed exposure
  • Smoker's skin
  • Stressed skin
  • Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
  • Post-acne skin rehabilitation
  • Atrophic scars
  • Stretch marks
  • Biostimulation of the face, neck, hands and decollete

Professional use

Viscoderm 1.6 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.

Treatment areas

  • Face
  • Neck
  • Hands
  • Decollete

Patient profile

Viscoderm 1.6 is intended for adult patients with moderate age-related skin changes, dry, stressed or sun-damaged skin, or skin requiring biostimulation of the face, neck, hands or decollete, including post-acne rehabilitation, atrophic scars and stretch marks. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.

How Viscoderm 1.6 Works

Viscoderm 1.6 works through native hyaluronic acid, 24 mg per 1.5 ml syringe, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected into the dermis it restores the skin's hyaluronic acid pool and biostimulates the tissue, which improves hydration, elasticity and texture. The mid-range concentration makes it suitable for moderate age-related change across larger areas such as the neck, hands and decollete as well as the face.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.

Frequently Asked Questions

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.

Which areas is Viscoderm 1.6 used on?

Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.

What does a Viscoderm 1.6 pack contain?

Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.

What does biostimulation with Viscoderm 1.6 target?

Biostimulation with Viscoderm 1.6 targets skin hydration, elasticity and texture, and the visible signs of age-related skin change, rather than adding volume to a specific line or fold.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

/ Specifications

The datasheet

Brand
VISCODERM
Laboratory
IBSA
SKU
11211
Format
3 x 1,5 mL
Origin
Italy
Indication
Biorevitalisation, biostimulation, age-related skin change
Use
Injectable gel implant, professional use
Treatment areas
/ Product details

The full file

Viscoderm 1.6 is an injectable biorevitalisation gel implant by Viscoderm, containing 24 mg of native hyaluronic acid per 1.5 ml syringe, with a molecular weight similar to endogenous hyaluronic acid. It is typically chosen by clinics, dermatologists and aesthetic practitioners for biostimulation of the face, neck, hands and decollete. The hyaluronic acid is obtained by biofermentation from natural raw materials and produced without chemical modification, and the product is developed for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, tracked and insured, with 24-72h dispatch. Each unit ships with batch number and expiry, held in EU bond and batch-traceable.

Store to manufacturer specification, away from direct light. Cold-chain is only used where the product requires it.

Net 30 / 60 / 90 day terms* are available to verified accounts on credit approval. Invoicing is supported in EUR, CHF and GBP.

Terms are indicative and confirmed after account review.

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.

Which areas is Viscoderm 1.6 used on?

Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.

What does a Viscoderm 1.6 pack contain?

Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.

What does biostimulation with Viscoderm 1.6 target?

Biostimulation with Viscoderm 1.6 targets skin hydration, elasticity and texture, and the visible signs of age-related skin change, rather than adding volume to a specific line or fold.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

/ Quick answers

Everything a buyer asks first

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?
Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.
Which areas is Viscoderm 1.6 used on?
Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.
What does a Viscoderm 1.6 pack contain?
Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.
/ FAQ

Frequently asked

Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.
Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.
Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.
Biostimulation with Viscoderm 1.6 targets skin hydration, elasticity and texture, and the visible signs of age-related skin change, rather than adding volume to a specific line or fold.
Viscoderm 1.6 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory

Clinic alternatives

All products

Viscoderm 1.6

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Viscoderm 1.6 is an injectable biorevitalisation gel implant by Viscoderm, containing 24 mg of native hyaluronic acid per 1.5 ml syringe, with a molecular weight similar to endogenous hyaluronic acid. It is typically chosen by clinics, dermatologists and aesthetic practitioners for biostimulation of the face, neck, hands and decollete. The hyaluronic acid is obtained by biofermentation from natural raw materials and produced without chemical modification, and the product is developed for professional use by qualified practitioners.

Key Benefits of Viscoderm 1.6

  • Contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml
  • Supports skin biostimulation and biorevitalisation
  • Improves hydration and skin elasticity
  • Improves skin texture and the appearance of age-related skin changes
  • Formulated for the face, neck, hands and decollete
  • Native hyaluronic acid, obtained by biofermentation and not chemically modified
  • Supports good biocompatibility and tolerability
  • Suitable for different professional injection techniques
  • Sterile and apyrogenic syringe content
Key Information
Brand Viscoderm
Manufacturer IBSA
Country of Origin Italy
Certification Classified as a medical product
Ingredients Native hyaluronic acid, obtained by biofermentation and not chemically modified
Volume / Size 1.5 ml per syringe, 4.5 ml per pack
Packaging 3 syringes x 1.5 ml, with 6 needles 30G x 12 mm
Needle Size 30G x 12 mm, 6 needles supplied per pack
Use Type Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.

Indications and Professional Use

Main indications

  • Moderate age-related skin changes
  • Genetically dry skin prone to fine lines
  • Skin affected by frequent or prolonged sunbed exposure
  • Smoker's skin
  • Stressed skin
  • Skin requiring improved adaptive capacity during acne, pigmentation or aggressive aesthetic treatment courses
  • Post-acne skin rehabilitation
  • Atrophic scars
  • Stretch marks
  • Biostimulation of the face, neck, hands and decollete

Professional use

Viscoderm 1.6 is an injectable gel implant supplied for professional use only and must be administered by qualified medical practitioners. The syringe content is sterile and apyrogenic, the product is single-use, and aseptic technique applies throughout; any unused content is discarded. The product suits different professional injection techniques, and the treating practitioner determines the technique, injection plane, dose per point and session interval for each indication and treated area. Treatment is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scar formation, blood coagulation disorders, and in patients using anticoagulant or antiplatelet agents.

Treatment areas

  • Face
  • Neck
  • Hands
  • Decollete

Patient profile

Viscoderm 1.6 is intended for adult patients with moderate age-related skin changes, dry, stressed or sun-damaged skin, or skin requiring biostimulation of the face, neck, hands or decollete, including post-acne rehabilitation, atrophic scars and stretch marks. Suitability is determined by the treating practitioner following clinical assessment. It must not be used in patients with hypersensitivity to any component of the preparation, in pregnancy or breastfeeding, in acute infectious or inflammatory disease, in autoimmune disease, in patients prone to hypertrophic or keloid scarring, in patients with blood coagulation disorders, or in patients taking anticoagulants or antiplatelet agents.

How Viscoderm 1.6 Works

Viscoderm 1.6 works through native hyaluronic acid, 24 mg per 1.5 ml syringe, obtained by biofermentation from natural raw materials and supplied without chemical modification, so its molecular weight is similar to the hyaluronic acid already present in the skin. Injected into the dermis it restores the skin's hyaluronic acid pool and biostimulates the tissue, which improves hydration, elasticity and texture. The mid-range concentration makes it suitable for moderate age-related change across larger areas such as the neck, hands and decollete as well as the face.

Why Order From Allpara

Allpara offers genuine, verified VISCODERM products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.

Frequently Asked Questions

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.

Which areas is Viscoderm 1.6 used on?

Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.

What does a Viscoderm 1.6 pack contain?

Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.

What does biostimulation with Viscoderm 1.6 target?

Biostimulation with Viscoderm 1.6 targets skin hydration, elasticity and texture, and the visible signs of age-related skin change, rather than adding volume to a specific line or fold.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

More from IBSA

View laboratory →

Viscoderm 1.6 is an injectable biorevitalisation gel implant by Viscoderm, containing 24 mg of native hyaluronic acid per 1.5 ml syringe, with a molecular weight similar to endogenous hyaluronic acid. It is typically chosen by clinics, dermatologists and aesthetic practitioners for biostimulation of the face, neck, hands and decollete. The hyaluronic acid is obtained by biofermentation from natural raw materials and produced without chemical modification, and the product is developed for professional use by qualified practitioners.

IBSA, country of origin Italy.

Shipped EU-wide from our EU warehouse, 24-72h dispatch, tracked and insured. Each unit ships with batch number and expiry, held in EU bond and batch-traceable. Store to manufacturer specification.

Net 30 / 60 / 90 day terms* for verified accounts on credit approval. Invoicing in EUR, CHF and GBP.

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

Viscoderm 1.6 contains 24 mg of native hyaluronic acid per 1.5 ml syringe, equivalent to 16 mg/ml, and is supplied as 3 syringes of 1.5 ml. Viscoderm 0.8 is the lighter option at 8 mg/ml in 1 ml syringes, formulated for especially thin and delicate skin, while Viscoderm 2.0 is the strongest at 2.0% for mature or dehydrated skin needing more restructuring.

Which areas is Viscoderm 1.6 used on?

Viscoderm 1.6 is indicated for biostimulation of the face, neck, hands and decollete.

What does a Viscoderm 1.6 pack contain?

Each pack contains 3 syringes of 1.5 ml and 6 needles of 30G x 12 mm.

What does biostimulation with Viscoderm 1.6 target?

Biostimulation with Viscoderm 1.6 targets skin hydration, elasticity and texture, and the visible signs of age-related skin change, rather than adding volume to a specific line or fold.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 is contraindicated in hypersensitivity to any component of the preparation, pregnancy and breastfeeding, acute infectious or inflammatory disease, autoimmune disease, a tendency to hypertrophic or keloid scarring, blood coagulation disorders, and use of anticoagulant or antiplatelet medication.

* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.